Alan R. Stewart
CIK 1705492 · Chief Financial Officer · last filed 2026-05-21
Alan R. Stewart is a Chief Financial Officer who has filed 45 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for SSTI, was dated May 21, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.00M
3
45
-$1.15M
Holdings By Company
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | SSTI | Grant (A) | +74,963 | $0 | EDGAR |
| 2025-07-15 | CLDI | Grant (A) | — | $0 | EDGAR |
| 2025-03-04 | SSTI | Mixed | +26,562 | -$157.7K | EDGAR |
| 2025-01-03 | CLDI | Grant (A) | +12,771 | $0 | EDGAR |
| 2024-12-12 | SSTI | Sell (S) | −15,000 | -$209.3K | EDGAR |
| 2024-10-15 | Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-02 | Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Grant (A) | +25,995 | $0 | EDGAR |
| 2024-07-02 | Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted | Grant (A) | +73,437 | $0 | EDGAR |
| 2024-05-21 | SSTI | Grant (A) | +7,308 | $104.9K | EDGAR |
| 2024-04-03 | SSTI | Grant (A) | +24,295 | $0 | EDGAR |